Glenmark Pharma Q3 PAT rises 21.3% to Rs 290.8 crore
News2023-02-10
2 Views
Consolidated revenue was at Rs 3,463.9 crore, as against Rs 3,173.4 crore, up 9.2 per cent, Glenmark Pharmaceuticals said.
Latest News from Moneycontrol.com
The news, reports, views and opinions of authors (or source) expressed are their own and do not necessarily represent the views of CRWE World.
Breaking News: National Junior College/Prep Football League Launches to Empower High School Athletes On and Off the Field
